Amitriptyline 10 & 50mg: Ndma And Nnort Impurity
Amitriptyline 10mg and 50mg Recall Amitriptyline tablets in 10mg and 50mg strengths are being recalled across Canada because they contain higher-than-acceptable levels of NDMA and NNORT impurities. These impurities are chemical contaminants that formed during manufacturing. This is a Class I recall, meaning the product poses a serious health risk.
- Product
- AMITRIPTYLINE 10 & 50mg
- Reason
- Contamination
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2023-08-16
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/fc89fdbf-fd09-42da-990b-3f8811187779